Amyotrophic Lateral Sclerosis with Anti-acetylcholine Receptor Antibody
Overview
Affiliations
We report a case of amyotrophic lateral sclerosis (ALS) with anti-acetylcholine receptor (AChR) antibody in a 73-year-old female patient. She showed the typical course of ALS. She had no clinical findings of myasthenia gravis and had never undergone neurotoxin therapy using snake venom. Anti-AChR antibody was positive with a titer of 0.50 nmol/l on admission. We traced the titers during the progression of ALS; the titer was positive when muscle weakness worsened, and it became negative when the general condition became stable. We suppose that the occurrence of anti-AChR antibody may be partially relevant with abnormalities at the neuromuscular junction during the progression of ALS.
Amyotrophic lateral sclerosis and myasthenia gravis overlaps syndrome: a series of case report.
Wang H, Chen N, Jian F, Zhang Z, Tai H, Pan H Neurol Sci. 2024; 45(7):3549-3553.
PMID: 38403672 DOI: 10.1007/s10072-024-07369-z.
Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis.
Verma S, Khurana S, Vats A, Sahu B, Ganguly N, Chakraborti P Mol Neurobiol. 2022; 59(3):1502-1527.
PMID: 34997540 DOI: 10.1007/s12035-021-02658-6.
Imaging immunological processes from blood to brain in amyotrophic lateral sclerosis.
Amor S, Nutma E, Marzin M, Puentes F Clin Exp Immunol. 2021; 206(3):301-313.
PMID: 34510431 PMC: 8561688. DOI: 10.1111/cei.13660.
Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture.
Koneczny I, Herbst R Cells. 2019; 8(7).
PMID: 31269763 PMC: 6678492. DOI: 10.3390/cells8070671.
Ptosis and bulbar onset: an unusual phenotype of familial ALS?.
De Marchi F, Corrado L, Bersano E, Sarnelli M, Solara V, DAlfonso S Neurol Sci. 2017; 39(2):377-378.
PMID: 29134445 DOI: 10.1007/s10072-017-3186-0.